On July 10, Moderna announced FDA approval of its Spikevax® COVID shot for high-risk children aged 6 months to 11 years. The decision was made without the knowledge of Secretary Kennedy, head of the department overseeing the FDA. This is despite Moderna scientists admitting “unacceptable toxicity” in mRNA vaccines, citing concerns with lipid nanoparticles, production methods, and protein expression—raising serious questions about safety and oversight.
FDA Approved Moderna COVID Shot for Kids Behind Kennedy’s Back—Two HHS Aides Fired
